Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 2 Head & Neck 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Paclitaxel 161 Fulvestrant 155 Trastuzumab 152 pembrolizumab 144 Letrozole 136 Carboplatin 118 pertuzumab 104 Cyclophosphamide 102 Capecitabine 102 Specimen Handling 101 Anastrozole 90 palbociclib 85 abemaciclib 81 Magnetic Resonance Spectroscopy 81 exemestane 76 Docetaxel 76 Tamoxifen 75 ribociclib 73 trastuzumab deruxtecan 69 Radiotherapy 61 Biopsy 59 Surveys and Questionnaires 56 Gemcitabine 52 130-nm albumin-bound paclitaxel 52 sacituzumab govitecan 50 olaparib 50 Standard of Care 49 Blood Specimen Collection 49 Taxes 47 Doxorubicin 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

WW Domain-Containing Oxidoreductase × Breast × 1 year × Clear all

NCT07394946 2026-02-20

NELOPHER

Cancer Care Hospital & Research Centre Foundation, Lahore

Phase 2 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡